Mark Kirschbaum

Insider Reports History

Entity
Individual
Location
66 West 38 Th Street, Apt. 19 D, New York, NY
Signature
/s/ Mark Kirschbaum
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark Kirschbaum:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Cyclacel Pharmaceuticals, Inc. Chief Medical Officer Common Stock 31.2K $103K $3.32 Jan 31, 2023 Direct
Cyclacel Pharmaceuticals, Inc. Chief Medical Officer Stock Option (right to buy) 70.2K Jun 30, 2023 Direct

Insider Reports Filed by Mark Kirschbaum

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CYCC Cyclacel Pharmaceuticals, Inc. Jun 30, 2023 1 $0 4 Jul 3, 2023 Chief Medical Officer
CYCC Cyclacel Pharmaceuticals, Inc. Jan 31, 2023 1 $0 4 Feb 2, 2023 Chief Medical Officer
CYCC Cyclacel Pharmaceuticals, Inc. Dec 13, 2021 1 $0 4 Dec 15, 2021 Chief Medical Officer